This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]

United States Department of Health and Human Services
Decorative bullet image: Home
Decorative bullet image: Questions?
Decorative bullet image: Contact Us
Decorative bullet image: Site Map
HHS Logo Bottom
spacer image
    

Assistant Secretary for Legislation (ASL)

Testimony

Calendar Year 2004 Congressional Testimony

2004 ~2003 ~2002~2001~2000~1999~1998~1997~1996
Jan ~Feb ~Mar~Apr~May ~Jun~Jul~Aug~Sep~Oct

Search Testimony database

October 6, 2004-- Stephen Ostroff, M.D., Deputy Director, National Center for Infectious Disease, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Public Health Response to West Nile Virus
Before: The Committee on Government Reform, Subcommittee on Energy Policy, Natural Resources, and Regulatory Affairs, United States House of Representatives

October 6, 2004-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NIH's Biomedical Research Response to West Nile Virus
Before: The Committee on Government Reform, Subcommittee on Energy Policy, Natural Resources, and Regulatory Affairs, U.S. House of Representatives

October 5, 2004-- William Egan, Ph.D., Acting Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Department of Health and Human Services
Subject: Influenza Vaccine
Before: Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Committee on Appropriations

October 5, 2004-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Subject: NIH role in the research and development of safer and more effective vaccines against infectious diseases
Before: The Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education, U.S. House of Representatives

October 5, 2004-- Julie Louis Gerberding, MD, MPH, Director, Centers for Disease Control and Prevention, Administrator, Agency for Toxic Substances and Disease Registry, Department of Health and Human Services
Subject: Influenza and Influenza Vaccine Safety and Supply
Before: The Committee on Appropriations, Subcommittee on Labor, Health and Human Services, & Education, U.S. House of Representatives

October 5, 2004-- Lynn C. Swann, Chairman, President's Council on PHysical Fitness and Sports, Office of Public Health and Science, U.S. Department of Health and Human Services
Subject: Combating the Epidemic of Childhood Obesity
Before: Committee on Health, Education, Labor, and Pensions, United States Senate

October 5, 2004-- Dixie E. Snider, Jr., MD, MPH, Acting Chief of Science, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Reducing Childhood Obesity: HHS' Public Health Response
Before: The Committee on Health, Education, Labor & Pensions, United States Senate

September 28, 2004-- Pamela McInnes, D.D.S., M.Sc. (Dent.), Deputy Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NIH's Biomedical Research Response to Influenza
Before: The Special Committee on Aging, United States Senate

September 28, 2004-- Stephen Ostroff, M.D., Deputy Director, National Center for Infectious Disease, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Combating the Flu: Keeping Seniors Alive
Before: The Special Committee on Aging, United States Senate

September 21, 2004-- Carolyn Clancy, M.D., Director, Agency for Healthcare Research and Quality
Subject: Clinical Preventive Services: The U.S. Preventive Services Task Force and the Role of the Agency for Healthcare Research and Quality
Before: Subcommittee on Health House Energy and Commerce Committee

September 15, 2004-- Ed Thompson, M.D., M.P.H., Chief, Pubic Health Practice,Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Conquering Obesity: The U.S Approach to Combating this National Health Crisis
Before: The Subcommittee on Human Rights and Wellness Committee on Government Reform

September 14, 2004-- Mark McClellan, MD., Ph.D., Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Titles I and II: Features of the Proposed Regulations
Before: Senate Finance Committee

September 9, 2004-- Janet Woodcock, M.D., Acting Deputy Commissioner for Operations, U.S. Food and Drug Administration, Department of Health and Human Services
Subject: Publication and Disclosure Issues in Anti-Depressant Pediatric Clinical Trials
Before: Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

September 8, 2004-- John Howard, M.D., M.P.H., Director, National Institute for Occupational Safety and Health, Centers for DIsease Control and Prevention, U.S. Deparment of Health and Human Services
Subject: Assessing 9/11 Health Effects
Before: The Subcommittee on National Security, Emerging Threats, and International Relations Committee on Government Reform, United States House of Representatives

September 8, 2004-- William Egan, Ph.D., Acting Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Department of Health and Human Services
Subject: Truth Revealed: New Scientific Discoveries Regarding Mercury in Medicine and Autism
Before: Committee on Government Reform Subcommittee on Human Rights & Wellness Hearing

September 8, 2004-- Melinda Wharton, M.D., P.P.H., Acting Deputy Director, National Immunization Program, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Truth Revealed: New Scientific Discoveries Regarding Mercury in Medicine and Autism
Before: House Government Reform Committee Subcommittee on Wellness and Human Rights

August 26, 2004-- Stewart Simonson, Assistant Secretary, Office of Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: Safeguarding the Nation: HHS and VA Emergency Preparedness Collaborations
Before: United States House of Representatives, Committee on Veterans Affairs

July 22, 2004-- Barbara Alving, M.D., MACP, Acting Director, National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Balancing Act: The Health Advantages of Naturally-Occurring Hormones in Hormone Replacement Therapy
Before: The Subcommittee on Human Rights and Wellness, Committee on Government Reform, United States House of Representatives

July 22, 2004-- John M. Taylor, III, Associate Commissioner for Regulatory Affairs, U.S. Food and Drug Administration
Subject: Internet Drugs
Before: Permanent Subcommittee on Investigations, Committee on Governmental Affairs, United States Senate

July 22, 2004-- James Lubitz, Acting Chief, Aging and Chronic Diseases, Statistics Branch, National Center for Health Statistics, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Helping those who need it most: Low-income seniors and the new Medicare Law
Before: The Joint Economic Committee, United States Congress

July 22, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Administration's efforts to increase the use of information technology throughout the health care industry
Before: House of Representatives Committee on Energy and Commerce, Subcommittee on Health

July 21, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Reauthorization of the Indian Health Care Improvement Act (IHCIA)
Before: U.S. Senate Committee on Indian Affairs

July 20, 2004-- Charles G. Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration, Dept. of Health and Human Services
Subject: Performance Measurement and Performance Management
Before: Subcommittee on Substance Abuse and Mental Health Committee on Health, Education, Labor and Pensions United States Senate

July 20, 2004-- Dr. Ed. Sontag, Assistant Secretary for Administration and Management and Chief Human Capital Officer
Subject: Federal Hiring Reform
Before: Subcommittee on Oversight of Government Management, the Federal Workforce and the District of Columbia Committee on Governmental Affairs, United States Senate

July 19, 2004-- Mark McClellan, MD, Ph.D, Administrator, Centers for Medicare & Medicaid Services, Department of Health and Human Services
Subject: Helping Those Who Need It Most: Low-Income Seniors and The New Medicare Law
Before: Senate Committee on Aging

July 15, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Preventing Chronic Disease throught Heathly Lifestyle
Before: United States Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education

July 14, 2004-- William K. Hubbard, Associate Commissioner for Policy Planning, U.S. Food and Drug Administration
Subject: Hearing: Issues relating to the Importation of Prescription Drugs into the U.S. and the use of the Internet to facilitate the sale of these drugs.
Before: Committee on the Judiciary, U.S. Senate

July 13, 2004-- Statement from the U.S. House of Health and Human Services
Subject: H.R. 4057, the "Samaritan Initiative Act of 2004"
Before: Subcommittee on Housing and Community Opportunity Committee on Financial Services, US House of Representatives

July 8, 2004-- Allen M. Spiegel, M.D., Director, National Institue of Diabetes and Digestive and Kidney Diseases, National Institues of Health, U.S. Department of Health and Human Services
Subject: Assessing Digestive Diseases Research and Treatment Opportunities
Before: Committee on Energy and Commerce, Subcommittee on Health

July 8, 2004-- Christopher Gersten, Principal Deputy Assistant Secretary Administration for Children and Families, HHS
Subject: Hearing: Families activities under the Trafficking Victims Protection Act of 2000 (TVPA)
Before: House Government Reform Committee Subcommittee on Human Rights and Wellness

June 25, 2004-- Lester M. Crawford, Acting Commissioner, Food and Drug Admininstration, Department of Health and Human Services
Subject: Hearing: Implementation of the Food Security Provisions of the Public Health Security and Bioterrorism Preparedness and Response Act
Before: Committee on Energy and Commerce

June 24, 2004-- Donald A. Young, MD, Deputy Assistant Secretary for Planning Evaluation HHS
Subject: HHS Programs for People with Disabilities
Before: Committee on Government Reform - Subcommittee on Human Rights and Wellness U.S. House of Representatives

June 23, 2004-- Lester M. Crawford, D.V.M., Ph.D., Acting Commissioner of Food and Drugs, Department of Health and Human Services
Subject: The Law of Biologic Medicine
Before: The Committee on the Judiciay/US Senate

June 22, 2004-- Elias A. Zerhouni, Director, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Hearing: NIH Ethics Concerns: Consulting Arrangements and Outside Awards
Before: The Oversight and Investigations Subcommittee, Committee on Energy and Commerce, United States House of Representatives

June 22, 2004-- Alex Azar, General Counsel, Department of Health and Human Services
Subject: Hearing: NIH Ethics Concerns: Consulting Arrangements and Outside Awards
Before: The Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, United States House of Representatives

June 17, 2004-- David J. Brailer, M.D., Ph.D., National Coordinator for Health Information Technology, Office of the Secretary, U.S. Department of Health and Human Services
Subject: Hearing: Health Information Technology
Before: Subcommittee on Health, Committee on Ways and Means

June 16, 2004-- Howell Wechsler, Ed.D., M.P.H., Acting Director, Division of Adolescent and School Health, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: HHS Efforts to Combat The Obesity Epidemic Among Children and Adolescents
Before: Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, United States House of Representatives

June 15, 2004-- Charles G. Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration
Subject: Hearing: Providing Substance Abuse and Mental Health Prevention and Treatment Services to Adolescents
Before: Subcommittee on Substance Abuse and Mental Health Services, Committee on Health, Education, Labor and Pensions, U.S. Senate

June 8, 2004-- Quanah Crossland Stamps, Admin for Native Americans, HHS
Subject: Native American Programs Act (NAPA)
Before: Committe on Indian Affairs, U.S. Senate

June 8, 2004-- Mark McClellan, M.D., Ph.D., Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Medicare Prescription Drug Discount Program
Before: Senate Finance Committee

June 8, 2004-- Robert E. Brackett, Ph.D., Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration
Subject: "Dietary Supplement Safety Act: How is FDA Doing After 10 Years?"
Before: Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, The Federal Workforce, and the District of Columbia, United States Senate

June 8, 2004-- Joe Sniezek, M.D., M.P.H., Director, Arthritis Program, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Role in Combating the Burden of Arthritis
Before: Subcommittee on Aging, Committee on Health, Education, Labor, and Pensions, U.S. Senate

June 8, 2004-- Susana Serrate-Sztein, M.D., Chief, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Arthritis: A National Epidemic
Before: Subcommittee on Aging, Committee on Health, Education, Labor and Pensions U.S. Senate

June 3, 2004-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Dept. of Health and Human Services
Subject: The NIH Biomedical Research Response to the Threat of Bioterrorism
Before: The Select Committee on Homeland Security, United States House of Representatives

May 20, 2004-- John M. Taylor, Associate Commissioner for Regulatory Affairs, Food and Drug Administration
Subject: Drug Reimportation
Before: Committee on Health, Education, Labor and Pensions, United States Sente

May 20, 2004-- Mark McClellan, Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Medicare-Approved Drug Discount Card
Before: The House Energy and Commerce Subcommittee on Health

May 20, 2004-- Wade Horn, PH.D, Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Subject: HHS - Statement For May 20th Hearing
Before: The Committee on Government Reform, U.S. House of Representatives

May 18, 2004-- Steven Gutman, M.D., Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, Food and Drug Administration, Dept. of Health and Human Services
Subject: NIH Ethics Concerns: Consulting Arrangements and Outside Awards
Before: Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, U.S. House of Representative

May 18, 2004-- Steven Gutman, M.D., Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, Food and Drug Administration, Dept. of Health and Human Services
Subject: Laboratory Operations at Maryland General Hospital
Before: Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, U.S. House of Representative

May 18, 2004-- Emanuel F. Petricoin, Ph.D., Senior Investigator, Office of Cell Tissue and Gene Therapies, Center for Biologics Evaluation and Research
Subject: NIH Ethics Concerns: Consulting Arrangements and Outside Awards
Before: House Investigation and Oversight Subcommittee

May 18, 2004-- Sean Tunis, M.D., Chief Clinical Officer and Director, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Dept. of Health and Human Services
Subject: Laboratory Operations at Maryland General Hospital
Before: Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the House Committee on Government Reform

May 13, 2004-- Richard Pazdur, M.D., Director, Division of Oncology Drug Products, Centers for Drug Evaluation and Research, Food and Drug Administration, Dept. of Health and Human Services
Subject: Harnessing Science: Advancing Care By Accelerating The Rate of Cancer Clinical Trial Participation
Before: Committee on Government Reform, U.S. House of Representatives

May 13, 2004-- Michaele Chamblee Christian, M.D., Associate Director, Division of Cancer Treatment and Diagnosis, Cancer Evaluation Therapy Program, National Cancer Institute, National Institutes Health, Dept. of Health and Human Services
Subject: Delivering More Innovative and Effective Treatments To make cancer a more Treatable Disease
Before: Committee on Government Reform, U.S. House of Representatives

May 13, 2004-- Wade Horn, PH.D Assist Secretary for Children and Families, HHS
Subject: Child and Family Services Reviews
Before: The Committee on Ways and Means-Subcommittee on Human Resources U.S. Representatives

May 13, 2004-- Richard Pazdur, M.D., Director, Division of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services
Subject: Harnessing Science: Advance Care By Accelerating The Rate of Cancer Clinical Trial Participation
Before: Commitee on Government Reform, U.S House of Representatives

May 12, 2004-- Peter C. Van Dyck, M.D., M.P.H., Associate Administrator for Child and Maternal Health, Health Resources and Services Administration, Dept. of Health and Human Services
Subject: Meeting the Challenges of Prematurity: HRSA Treatment Efforts
Before: The Subcommittee on Children and Families, Committee on Health, Eduction, Labor and Pensions U.S. Senate

May 12, 2004-- Elias A. Zerhouni, M.D., Director, National Institute of Health, Department of Health and Human Services
Subject: NIH Ethics Concerns: Consulting Arrangements and Outside Awards
Before: Committee on Energy and Commerce, United States House of Representatives

May 12, 2004-- Eve Lackritz, M.D., Chief, Maternal and Infant Health Branch Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Dept. of Health and Human Services
Subject: Meeting the Challenges of Prematurity: CDC Prevention Efforts
Before: Subcommittee on Children and Families, Committee on Health, Education, Labor and Pensions, US Senate

May 12, 2004-- Duane F. Alexander, M.D., Director, National Institute of Child Health Human Development, National Institutes of Health, Dept. of Health and Human Services
Subject: Meeting the Challenges of Prematurity: NIH Research Efforts
Before: Subcommittee on Children and Families, Committee on Health, Education, Labor and Pensions, US Senate

May 11, 2004-- William F. Raub, Ph.D., Principal Deputy Assistant Secretary, Office of the Assistant Secretary for, Public Health Emergency Preparedness, Department of Health and Human Services
Subject: HHS, the Department of Homeland Security and H.R. 3266
Before:The Subcommittee on Health Committee on Energy and Commerce, United States House of Representatives

May 11, 2004-- Mark McClellan, M.D. Ph.D., Administrator, Centers for Medicare and Medicaid Services
Subject: Chronic Care Improvement Initiative
Before:Subcommittee on Health of the House Committee on Ways & Means

May 3, 2004-- Charles A. Schable, M.S., Director, Bioterrorism Preparedness and Response Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC Bioterrorism Preparedness Efforts: Protecting the Public Health
Before: The Committee on Science, United States House of Representatives

April 28, 2004-- Wade F. Horn, PH.D, Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Before: Committee on Health, Education, Labor and Pensions, Subcommittee on Children and Families, U.S. Senate

April 28, 2004-- Judith A. Salerno, M.D., M.S., Deputy Director, National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Research on Alzheimer's Disease, Parkinson's Disease and Diabetes at the Natonal Institute of Health
Before: The Subcommittee on Oversight and Investigations, Committee on Veterans Affairs, United States House of Representatives

April 28, 2004-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, Administrator, Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services
Subject: CDC's Terrorism and Global Diseae Detection Efforts
Before: Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

April 28, 2004-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institues of Health
Subject: NIH's Research Response to Emerging and Re-emerging Infections Diseases: Implications for Global Health
Before: Subcommittee on Labor, Health and Human Services, Education and Related Agencies

April 28, 2004-- Herb Kuhn, Director, Centers for Medicare and Medicaid Services
Subject: Power Operated Wheelchairs
Before: Senate Finance Committee

April 27, 2004-- William K. Hubbard, Associate Commissioner for Policy and Planning, Food and Drug Administration
Subject: International Trade and Pharmaceuticals
Before: Subcommittee on Health Care and Subcommittee on International Trade Committee on Finance, United States Senate

April 8, 2004-- Michael McMullan, Deputy Director, Centers for Medicare and Medicaid Services
Subject: Implementing the Medicare Prescription Drug Program
Before: Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, The Federal Workforce, and The District of Columbia

April 7, 2004-- Dennis Smith, Director, Centers Medicaid and State Operations, Centers for Medicare & Medicaid Services
Subject: The New Freedom Initiative
Before: Senate Finance Committee

April 7, 2004-- Jonathan H. Mermin, M.D., M.P.H., Public Health Epidemiologist, Country Director for GAP Uganda, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Fighting HIV/AIDS in Africa: A Progress Report on HHS/CDC Efforts
Before: Committee on Foreign Relations, Subcommittee on African Affairs, United States Senate

April 1, 2004-- Dennis Smith, Director, Centers for Medicare and Medicaid Services
Subject: Inter-Governmental Transfers: Violations of the Federal-State Medicaid Partnership or Legitimate State Budget Tool?
Before: House Energy and Commerce Committee, Subcommittee on Health

April 1, 2004-- Michael McMullan, Deputy Director, Center for Beneficiary Choices Centers for Medicare and Medicaid Services
Subject: Medicare Prescription Drug Discount Card and Transitional Assistance Program
Before: House Ways and Means Committee

April 1, 2004-- Leslie Norwalk, Esq., Acting Deputy Administrator, Centers for Medicare & Medicaid Services
Subject: 2004 Annual Reports of the Board of Trustees of the Federal OASDI and HI/SMI Trust Funds
Before: House Ways and Means Committee

April 1, 2004-- Jeff Flick, Regional Administrator, San Francisco Regional Office, Centers for Medicare and Medicaid Services
Subject: 2004 Annual Reports of the Board of Trustes of the Federal OASDI and HI/SMI Trust Funds
Before: House Ways and Means Committee

April 1, 2004-- Patrick J. Meehan, M.D., Deputy of Director for Program, National Center for Environmental Health, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Public Health Role in the Chemical Demilitarization Program
Before: Subcommittee on Terrorism, Unconventional Threats, and Capabilities Committee on Armed Services, United States House of Representatives

April 1, 2004-- Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Marijuana and Medicine: The Need for a Science-Based Approach
Before: House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources, United States House of Representatives

April 1, 2004-- Robert J. Meyer, M.D., Director, Office of Drug Evaluation II, Center for Drug Evaluation, and Research Food Drug Administration, HHS
Subject: FDA's Drug Approval Process
Before: Subcommitte on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform

March 30, 2004-- Robert E. Bracket, Ph.D., Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration
Subject: Single Food Agency
Before: Committee on Government Reform, Subcommittee on Civil Service and Agency Organization, United States House of Representatives

March 30, 2004-- John Howard, M.D., M.P.H., Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, U.S. Dept. of Health and Human Services
Subject: HHS Activities Under the Energy Employees Occupational Illness Compensation Program (EEOICP)
Before: The Committee on Energy and Natural Resources, United States Senate

March 25, 2004-- Wade F. Horn, PH.D, Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Subject: Headstart
Before: The Subcommittee on Labor, HHS, Education and Related Agencies, Committee on Appropriates, U.S. House of Representatives

March 25, 2004-- Elias A. Zerhouni, M.D., Director, National Institute of Health, U.S. Department of Health and Human Services
Subject: NIH: Enhancing Clinical Research
Before: Subcommittee on Health, Committee on Energy and Commerce, United States House of Representatives

March 25, 2004-- RG. Reid Lyon, PH.D, Chief, Child Development and Behavior Branch National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Headstart
Before: The Subcommittee on Labor, HHS, Education and Related Agencies, Committee on Appropriates, U.S. House of Representatives

March 23, 2004-- Robert E. Brackett, Ph.D., Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Department of Health and Human Services
Subject: Ten Years After the Implementation of DSHEA: The Status of Dietary Supplements in the United States.
Before: Committee on Government Reform, Subcommittee on Human Rights and Wellness, United States House of Representatives

March 23, 2004-- Richard J. Hodes, M.D., Director, National Institute on Aging
Subject: Alzheimer's Disease Research
Before: The Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education

March 18, 2004-- Carolyn Clancy, Director, Agency for Healthcare Research and Quality, Department of Health and Human Services
Subject: Health Care Quality Initiatives
Before: The Subcommittee on Health of The House Committee on Ways and Means

March 18, 2004-- William K. Hubbard, Associate Commissioner for Policy and Planning, Food and Drug Administration, Department of Health and Human Services
Subject: Internet Drug Sales
Before: Committee on Government Reform, House of Representatives

March 16, 2004-- Kerry Weems, Acting Assistant Secretary for Budget, Technology and Finance, Department of Health and Human Services
Subject: Information Security in the Federal Government: One year into the Federal Information Security Management Act
Before: The House Committee on Government Reform, Subcommittee on Technology, Information Policy, Intergovernmental Relations and the Census

March 11, 2004-- Ed Thompson, M.D., Deputy Director for Public Health Services, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Human Papillomavirus (HPV) and Cervical Cancer Prevention Activities
Before: Subcommittee on Criminal Justice, Drug Policy and Human Resources

March 11, 2004-- Dr. Mark B. McClellan, Commissioner of Food and Drugs, Food and Drugs Administration
Subject: Cost of Prescription Drugs
Before: Committee on Commerce Science and Transportation United States Senate

March 10, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS FY 2005 Budget
Before: The U.S. House of Representatives Committee on Energy and Commerce

March 9, 2004-- Dennis Smith, Acting Administrator, Centers for Medicare and Medicaid Services
Subject: Medicare Prescription Drug Discount Card and Tranistional Assistance Program
Before: Senate Special Committee on Aging

March 8, 2004-- Dr. Mark McClellan, Nomiee for Administrator, Centers for Medicare & Medicaid Services, Department of Health and Human Services
Subject: Confirmation Hearing
Before: Committee on Finance U.S. Senate

March 2, 2004-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Office of Public Health and Science, U.S. Department of Health and Human Services
Subject: The Growing Epidemic of Childhood Obesity
Before: The Subcommittee on Competition, Infrastructure and Foreign Commerce, Science, and Transportation

February 26, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS FY 2005 Budget
Before: U.S. House of Representatives, Committee on the Budget

February 25, 2004-- Nathan Stinson, Jr., Ph.D., M.D., M.P.H., Deputy Assistant, Secretary for Minority Health, Office of Public Health and Science, U.S. Department of Health and Human Services
Subject: HHS Health Care Activities in the Pacific Island Territories
Before: The Subcommittee on Human Rights and Wellness, Committee on Government Reform, United States House of Representatives

February 25, 2004-- Gary J. Hartz, P.E., Acting Director, Office of Public Health, Indian Health Service
Subject: Indian Health Services FY 2005 Budget
Before: Senate Committee on Indian Affairs

February 12, 2004-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Protecting the Pubic's Health: CDC Influenza Preparedness Efforts
Before: The Committee on Government Reform, United States House of Representatives

February 12, 2004-- Anthony Fauci, M.D, Director, National Institute of Allergy and Infectious Disease, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NIH's Biomedical Research Response to Influenza and Other Emerging and Re-emerging Infectious Diseases
Before: Committee on Government Reform United States House of Reprsentatives

February 10, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS FY 2005 Budget
Before: United States Senate Committee on the Budget

February 12, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS FY 2005 Budget
Before: U.S. House of Representatives Committee on Ways and Means

February 9, 2004-- Robert J. Meyer, M.D., Director, Office of Druge Evaluation II, Center For Drug Evaluation and Research, U.S. Food and Drug Administration
Subject: FDA's Drug Approval Process and Role in Preventing Prescription Durg Abuse
Before: U.S. House of Representatives, Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources

February 4, 2004-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS FY 2005 Budget
Before: U.S. Senate Committee on Finance

January 29, 2004-- Phillip Baker, Ph.D., Lyme Disease Program Officer, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NIH Lyme Disease Research
Before: Connecticut Department of Public Health and the Connecticut Attorney General's Office

January 29, 2004-- Paul Mead, M.D., M.P.H., Medical Epidemiologist, Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Center for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Lyme Disease Prevention and Control Activities
Before: Connecticut Department of Public Health and the Connecticut Attorney General's Office

January 28, 2004-- Wade F. Horn, Ph.D., Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Subject: Federal Child Welfare Oversight
Before: Committee on Ways and Means, Subcommittee on Human Resources, U.S. House of Representatives

January 27, 2004-- Lester M. Crawford, D.V.M., Ph.D., Deputy Commissioner of Food and Drugs, Department of Health and Human Services
Subject: Bovine Spongiform Encephalopathy (BSE)
Before: Committee on Agriculture, Nutrition and Forestry

January 22, 2004-- Elias Zerhouni, Md., Director, National Institutes of Health
Subject: Avoiding Conflicts of Interest at the National Institutes of Health
Before: Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies

January 22, 2004-- Ruth Kirchstein, M.D., Special Advisor to the Director, National Institutes of Health
Subject: Avoiding Conflicts of Interest at the National Institutes of Health
Before: Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies

January 22, 2004-- Edward M. Swindell, Associate General Counsel, Ethics Division Office of the General Counsel, United States Department of Health and Human Services
Subject: Avoiding Conflicts of Interest at the National Institutes of Health
Before: Committee on Appropriations, Subcommittee on Labor, Health and Human Services Education and Related Agencies

Last Revised: October 13, 2004

HHS Home | Questions? | Contact HHS | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers

The White House | FirstGov